Introduction {#s1}
============

Throughout adult life, new developmental commitment of adult stem cells may cause reversible metaplastic conversion to occur in some organs. For example, ectopic bone formation is common in surgical scars, muscle or walls of sclerotic arteries[@r1] and squamous metaplasia may appear in epithelia of the respiratory tract[@r2] or urinary bladder.[@r3] , [@r4] Barrett's metaplasia of the esophagus develops as a result of duodenal-esophageal reflex,[@r5] and gastric metaplasia in the duodenum[@r6] is observed with mucosal injury related to active duodenitis; both are due to greater acid output.

Intestinal metaplasia results from diverted differentiation of gastric stem cells towards cells of small intestine or colonic phenotypes and is characterized by the presence of intestinal-type, mucin-containing goblet cells, Paneth cells and absorptive cells.[@r7] , [@r8] It is more prevalent in men than in women, and an increase with age has been noted.[@r9] The frequency of intestinal metaplasia varies widely in different countries, areas and races.[@r10] In the stomach, it has been considered to be a possible precancerous state on the basis of epidemiological surveys.[@r7] , [@r10] Several authors have suggested that intestinal metaplasia could play a role in the development of gastric carcinomas,[@r9] but it is not generally termed precancer because it is common in benign conditions.[@r10] , [@r11] Moreover, its pathogenesis remains unclear. The present review describes findings on the induction of intestinal metaplasia for analysis of its relation to neoplasia, with a focus on stem cells having a multipotential ability to transdifferentiate when transplanted into different environments.

Classification of Intestinal Metaplasia {#s2}
=======================================

The small intestinal mucosa has been observed in human stomachs since the 19th century, and Sugimura *et al*. proposed classification into complete and incomplete types.[@r12] Histochemical and immunochemical stains that identify enzymes or mucosubstances have provided evidence that metaplastic epithelial cells resemble small or large intestinal cells. Teglbaerg and Nielsen[@r13] therefore subdivided the types into small intestinal and large intestinal types using periodate-borohydride/KOH/PAS and alcian blue pH 2.6-PAS methods. They suggested that intestinal metaplasia of the colonic type should have a certain premalignant potential, whereas intestinal metaplasia of the small intestinal type should merely be of reactive character, without such premalignant potential. They further described incomplete intestinal metaplasia to be a hybrid epithelium, with features of both gastric and intestinal mucosa. In addition, intestinal metaplasia has been classified by Jass and Filipe into three grades, complete or type I in which goblet cells contain sialomucin, incomplete without sulphomucins (type IIA) and incomplete with sulphomucins present in the colon (type IIB), and association with intestinal cancer has been suggested.[@r14]

We have proposed three different types of intestinal metaplasia from our experience with animal experiments,[@r15] one with goblet cells in the gastric mucosa (Type A, [Fig. 1](#f1){ref-type="fig"}); another with intestinal-type crypts without Paneth cells (Type B, [Fig. 2](#f2){ref-type="fig"}); and the last with intestinal-type crypts with Paneth cells (Type C, [Fig. 3](#f3){ref-type="fig"}). Recently, Tsukamoto *et al*.[@r16] reported intestinal metaplasia to be divided into two major types, a gastric and intestinal (GI) mixed type and a solely intestinal type (I) type, using gastric and intestinal cell markers.

X-ray Induced Intestinal Metaplasia and Its Properties {#s3}
======================================================

Dosing of X-ray on induction of intestinal metaplasia[@r17] -- [@r19] {#s3a}
---------------------------------------------------------------------

No intestinal metaplasia was induced by four X-ray doses of 1 Gy, but appreciable lesions were noted with six X-ray doses of 5 Gy for a total dose of 30 Gy. An increase in intestinal metaplasia was induced by two X-ray doses of 10 Gy each at a 3-day interval for a total dose of 20 Gy, but no gastric tumors appeared after 12 months. However, gastric tumors were induced after a single X-irradiation dose of 20 Gy, and the incidence was increased with two 20 Gy doses given at an interval of 1 week. In contrast, the incidence of intestinal metaplasia was decreased. Thus, these results provide evidence that the best induction of intestinal metaplasia was two X-ray doses of 10 Gy each at a 3-day interval for a total dose of 20 Gy in 5-week-old male rats.

Sequential development of intestinal metaplasia by X-ray exposure in rats[@r17] {#s3b}
-------------------------------------------------------------------------------

Goblet cells in the gastric mucosa (Type A) appeared 1 week after irradiation of two X-ray doses of 10 Gy with a 3-day interval. Intestinal-type crypts without Paneth cells (Type B, [Fig. 4](#f4){ref-type="fig"}) were seen 2 weeks after irradiation, and Paneth cells (Type C) were finally observed at the bottom of intestinal-type crypt with the brush border an upper part of the crypts 8 weeks after irradiation. Crypts that had alkaline phosphatase (ALP) activity ([Fig. 5](#f5){ref-type="fig"}) were also seen around 8 weeks after irradiation.

Strain and spices differences {#s3c}
-----------------------------

Strain differences in the susceptibility of rats to induction of intestinal metaplasia by X-irradiation were examined using gastric regions of 5-week-old male rats irradiated with a total dose of 20 Gy of X-rays given in two equal fractions separated by 3 days. Upon sacrifice at 6 months after the last irradiation, the number of intestinal metaplastic crypts positive for ALP was highest in Donryu rats and lowest in Copenhagen rats.[@r20] Morphologically, the numbers of crypts with intestinal metaplasia in the glandular stomachs of Donryu, Wistar, SD and F344 rats were higher than in ACI (MNNG-sensitive strain), Buffalo and Copenhagen rats.[@r21] Intestinal metaplasia was more frequently observed in the pyloric glands than in the fundic glands. The results demonstrate that induction of intestinal metaplasia by X-irradiation is greatly influenced by the strain of rat. However, intestinal metaplasia was not induced in mice[@r17] and Mongolian gerbils[@r22] using the same irradiation protocol.

Sex differences[@r23] , [@r24] {#s3d}
------------------------------

The influence of sex hormones on induction of intestinal metaplasia was examined in 5-week-old Crj/CD rats of both sexes. At the age of 4 weeks, animals were gonadectomized, and some groups of rats were given either testosterone or dimethyl estradiol (DES). One week after the operation, they were irradiated with two 10-Gy doses of X-rays to the gastric region at a 3-day interval for a total of 20 Gy. At termination of the experiment at 6 months after X-irradiation, the incidence of intestinal metaplasia with ALP-positive foci in males was significantly higher than in females, the orchidectomized males or the orchidectomized plus DES-treated rats. On the other hand, the incidence of intestinal metaplasia with ALP-positive foci in normal females appeared to be lower than in the ovariectomized females and was increased in rats by treatment with testosterone and decreased by treatment with DES. These results suggested a promoting role for testosterone in the development of intestinal ALP-positive lesions and indicated considerable heterogeneity between intestinal subtypes.

Genetic Alteration {#s4}
==================

Maintenance of intestinal differentiation appears to depend on the presence of *Cdx2*, an intestine-specific transcription factor, and loss *Cdx2* expression leads to focal gastric differentiation in the colon.[@r25] In contrast, aberrant expression of *Cdx2* in the upper gastrointestinal tract is a key event in the pathogenesis of Barrett's esophagus[@r26] and intestinal metaplasia in the stomach.[@r27] *Cdx2* expression correlates with development of intestinal metaplasia,[@r28] and the levels in the corpus lesser curvature significantly decrease after eradication of *Helicobacter pylori (H. pylori)*.[@r29] *Cdx1* [@r30] and *Cdx2* [@r31] are major transcription factors in the development of intestinal metaplasia, which is supported by transgenic mouse studies, which have shown that ectopic expression of either *Cdx1* or *Cdx2* in the gastric epithelium is sufficient to induce a metaplastic conversion.[@r32] , [@r37] It is considered that *Cdx2* is a master regulator of the intestinal differentiation program.

Judd *et al*.[@r33] reported that N/K-ATPase-deficient (*Atp4a(--/--)*) transgenic mice with gastric achlorhydria and hypergastrinemia develop incomplete intestinal metaplasia. Silberg *et al*.[@r27] found that ectopic expression of *Cdx2* in the gastric epithelium is sufficient to cause transdifferentiation of the gastric mucosa into intestinal-type cells. They also found that sucrose isomaltase (*SI*) was not activated in the transgenic mouse stomach. Mutoh *et al*.[@r32] reported that all of the gastric mucosal cells except enterochromaffin-like cells were completely replaced by intestinal-type cells, including goblet cells and absorptive cells, in another transgenic mouse strain in which *Cdx2* was expressed in parietal cells under the control of the *H^+^/K^+^-ATPase* promoter. In this case, parietal cells disappeared after approximately 6 weeks, and the pH in the stomach increased from 2 to more than 7. Differentiation of intestinal-type cells may be induced not only by the expression of *Cdx2*, but also by the loss of parietal cells in the transgenic stomach, as reported by Mutoh *et al.*.[@r32] Li *et al*.[@r34] found that GIF-11 *Runx3*^+^*p53*^+^ cells expressed *SI* when cultured and showed that some *Runx3* mouse gastric epithelial cells differentiated into intestinal-type cells that expressed *Cdx2*. Thus, Fukamachi *et al.* [@r35] suggested that gastric epithelium cells can differentiate into intestinal-type cells, probably due to expression of *Cdx2* when the function of Runx3 is impaired. In contrast, Yuasa *et al.* reported that X-irradiation-induced intestinal metaplasia is not associated with alterations of the *H-ras, K-ras* and *p53* genes.[@r36]

*Helicobacter pylori* Infection {#s4a}
-------------------------------

The discovery of *H. pylori* in adult patients by Marshall and Warren[@r37] was a major event in modern gastroenterology and was honored with the Nobel Prize in 2005. The WHO has classified *H. pylori* as a group I carcinogen for gastric carcinomas, and infected individuals have a two to eight times higher risk of stomach tumor development than the general population. Correa[@r38] , [@r39] suggested that chronic gastritis, gastric atrophy, intestinal metaplasia, dysplasia and gastric cancer develop stepwise. Eradication of *H. pylori* infection produces a marked increase in the regression rate of precancerous lesions and the relative risk of gastric atrophy and intestinal metaplasia.[@r39] Ito *et al*. followed up 22 patients in whom *H. pylori* had been eradicated 5 years previously and confirmed that glandular atrophy is reversible in both the gastric corpus and antrum.[@r40] They also demonstrated increased gastric acidity accompanied by an improvement of gastric atrophy 1 year after eradication.[@r41] Kashiwagi reported that the grade of reflux esophagitis improved in a 3-year follow-up group and that reflux esophagitis that develops after *H. pylori* eradication therapy rarely becomes a long-term clinical problem in patients who complete the treatment successfully.[@r42]

Wyatt *et al*. found that foci of gastric metaplasia in the duodenal epithelium were an acquired change and were more common in men, perhaps because of their greater acid output, and suggested that mucosal injury is related to active duodenitis.[@r43] Ford *et al.* provided evidence that *H. pylori* eradication with acid suppression improves healing of duodenal ulcers compared with acid suppression alone.[@r44] However, Hobsley *et al*. reported that duodenal ulcers could recur after eradication of *H. pylori* infection.[@r45] , [@r46] Thus, in human beings, *H. pylori* infection can cause reflux esophagitis, intestinal metaplasia in the glandular stomach and duodenal ulcers, but after eradication, all these lesions can recur.

In 1996, Hirayama *et al.* described a Mongolian gerbil model of human *H. pylori* infection with the bacteria detectable throughout a 12-month period and the resultant chronic active gastritis, peptic ulcers and intestinal metaplasia resembling lesions apparent in humans.[@r47] *H. pylori* infection in itself does not induce gastric tumors in Mongolian gerbils[@r51],[@r51]. Heterotopic proliferative glands, which finally included Paneth cells induced by *H. pylori* infection in the stomachs of Mongolian gerbils, were obviously reduced, with few remnants after eradication of *H. pylori*.[@r50] , [@r51] The researchers considered that metaplastic and heterotopic prolifetice glands are reversible on eradication. Mizoshita *et al.* suggested that intestinal metaplasia induced by *H. pylori* infection in Mongolian gerbils is a paracancerous phenomenon rather than a premalignant condition and that its infection may trigger intestinalization of both stomach cancers and non-neoplastic mucosa.[@r52]

Therefore, there are data suggesting that cancer and intestinal metaplasia arise from different cell lineages, such that intestinal metaplasia may not be a precursor lesion but rather a marker of increased risk.[@r53]

Mechanisms of Induction of Intestinal Metaplasia and Roles of Stem Cells {#s5}
========================================================================

The esophagus epithelium can undergo metaplastic change to become the gastric or duodenal epithelium,[@r1] , [@r5] , [@r54] , [@r55] the gastric epithelium can become the intestinal epithelium,[@r56] , [@r57] and vice versa[@r1] , [@r6] , [@r58] and the large intestinal epithelium can change to become the small intestinal epithelium[@r59] -- [@r61] under the influence of different gastrointestinal tract diseases. Thus, tissue differentiation in the gastrointestinal tract appears to be malleable. Wyatt *et al.* [@r43] found that foci of gastric metaplasia in the duodenal epithelium were an acquired change and again were more common in men, suggesting a relation for mucosal injury with active duodenitis.

The development of intestinal metaplasia with ALP-positive foci has been shown to be increased by administration of ranitidine, an H~2~ receptor antagonist,[@r24] or a crude stomach extract[@r19] and by pyloroplasty or pyloroplasty plus vagotomy.[@r62] On the other hand, intestinal metaplasia is decreased by cysteamine,[@r24] which stimulates gastric acid secretion, and histamine or removal of the submandibular glands.[@r63] A close relationship between the fundic pH and ALP-positive foci exists, and subtotal resection of the fundus increases the development of intestinal metaplasia induced by X-irradiation as assessed in terms of ALP-positive foci and total intestinal metaplasia.[@r64] The fact that goblet cells are observed in the pylorus until 7 days of age and then disappear by 14 days of age is in line with the concurrent decrease in the pH value with the increase in the number of parietal cells.[@r65]

On the other hand, as described above, metaplasia may disappear with *H. pylori* eradication and appears in *Cdx2* transgenic mice due to decrease in acid output. Therefore, taking all of the available findings into account, our working hypothesis is as follows: elevation of the gastric juice pH due to disappearance of parietal cells is one of the principal factors responsible for the development of intestinal metaplasia from gastric stem cells, and this process is reversible ([Fig. 6](#f6){ref-type="fig"}). In other words, it is considered that stem cells in intestinal metaplasia may newly differentiate into the gastric mucosa under acidic conditions.

Stem Cells {#s6}
==========

When gastric tissue was transplanted into the duodenum,[@r66] pepsinogen-positive chimeric glands with goblet cells appeared in the grafts. Esophageal grafts transplanted into the glandular stomach or duodenum similarly transdifferentiate into the mucosa of these respective sites. Moreover, we also founded that pieces of ear (skin), bladder, trachea, diaphragm, pyloric gland and forestomach from 8-week-old male GFP-F344 rats, when transplanted into the duodenums of F344 strain rats demonstrated goblet cells with alcian-blue PAS-positive mucin and brush borders with ALP.[@r67] A GFP-positive duodenal mucosa was observed in all cases by immunohistochemical staining. Moreover, the GFP-positive cells were found to have the GFP transgene by PCR analysis. In the duodenum, the microenvironment might thus be conducive to the development of metaplasia if it is associated with an increase in proliferation. As a result, the bladder, trachea, ear (skin), diaphragm, pyloric gland and forestomach tissue of the F344 rat contained stem cells that have multipotential ability for differentiation when transplanted into different environments.

Adult stem cells have been reported in several tissue sources, including the central nervous system,[@r68] bone marrow,[@r69] retina,[@r70] brain,[@r71] hair follicle,[@r72] inner ear,[@r73] adipose tissues,[@r74] oral mucosal epithelium,[@r75] liver,[@r76] skeletal muscle[@r77] and skin.[@r78] Heart, kidney, brain and skin pieces from male F344 transgenic rats carrying the *GFP* gene, when transplanted into F344 rats one day after intraperitoneal injection of carbon tetrachloride, transdifferentiate into hepatocytes.[@r79] Thus, tissue stem cells have multipotential ability. Other examples of extensive plasticity include the *in vivo* differentiation of a bone marrow population enriched for hematopoietic stem cells into mature hepatocytes in the livers of rodents[@r80] , [@r81] and derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation.[@r82] Such differentiation of bone marrow cells into mature cells of the liver has also been reported to occur in humans.[@r83] , [@r84] Together with the data presented here, the available findings indicate that mammalian stem cells persist in various organs and that such cells can be induced to undergo other organ differentiation with an appropriate microenvironment. Our experimental system with its unique feature of the GFP marker has clear advantages compared with previous animal models.

Correlation Between Intestinal Metaplasias and Gastric Tumors {#s7}
=============================================================

The colonic mucosa transplanted into the fundic gland lacks susceptibility to typical gastric carcinogens, MNNG[@r85] or MNU given orally,[@r54] but is sensitive to a colonic carcinogen, DMH.[@r86]

The incidences of gastric tumors against the frequency of intestinal metaplasia with or without Paneth cells per rat yielded a significant inverse relationship,[@r87] , [@r88] suggesting that the development of intestinal metaplasia and gastric tumors might be independent responses to treatment with MNNG or MNU. However, induction of an intestinal metaplastic mucosa in the glandular stomach by X-rays was associated with a greater tendency for tumorigenesis in response to DMH or AOM,[@r89] -- [@r91] in contrast to the non-susceptible normal gastric mucosa. Transplant experiments such as those reported here can be of assistance in clarifying the role of the microenvironment in determining the risk of tumorigenesis.

The number of intestinal metaplasias with ALP-positive foci induced by X-rays in the Donryu rats was decreased by the treatment with AOM, but aberrant crypt-like foci appeared within some of the affected areas, with the appearance of cystic structures with pyknotic nuclei exhibiting binding of anti-8-hydroxyguanosine antibodies.[@r91] Thus, it would appear that areas of intestinal metaplasia with or without Paneth cells induced by X-irradiation might be susceptible to colonic carcinogen damage. When male F344 rats were X-irradiated and AOM was injected and PhIP given by intragastric intubation 16 weeks after the first dose,[@r92] tumors in the pylorus of the glandular stomach were observed in 4 of 29 animals in the X-rays+AOM group and 4 of 25 animals receiving X-rays+PhIP after 12 months. No such lesions were found in the chemical or X-ray alone groups. Intestinal metaplasia and induced tumors were found to be positive for Cdx2 by histochemistry. In summary, the presence of intestinal metaplasia, with or without Paneth cells, may increase the sensitivity of the stomach to the induction of tumors by carcinogens like DMH, AOM and PhIP, but not MNNG or MNU. The results are compatible with the conclusion that intestinal metaplasias are targets of DMH-type carcinogens in the normal gastric mucosa ([Fig. 7](#f7){ref-type="fig"}). The protocol used in our studies may provide a new approach to distinguish between developmental events associated with intestinal metaplasia and gastric tumors.
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![Goblet cells with gastric mucosa (Type A). Alcian blue-PAS staining, ×200. Round and ultramarine stained goblet cells were found in PAS-positive (pink) gastric glands.](tox-23-115-g001){#f1}

![Intestinal crypt without Paneth cells (Type B). Alcian blue-PAS staining, ×200. PAS-negative glands have many goblet cells but no Paneth cells at the bottom.](tox-23-115-g002){#f2}

![Intestinal crypt with Paneth cells (Type C). Alcian blue PAS staining, ×200. Arrows: Paneth cells.](tox-23-115-g003){#f3}

![Gastric mucosa differentiating into an intestinal crypt. Alcian blue-PAS staining, ×200. Arrow: One side is PAS-positive gastric gland and in other hand intestinal type crypt.](tox-23-115-g004){#f4}
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![Working hypothesis for induction of intestinal metaplasia.](tox-23-115-g006){#f6}
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